Subscribe free

HPB & Spleen ·

Circulating tumor DNA methylation predicts outcomes in colorectal cancer

The study demonstrated that circulating tumor DNA (ctDNA) methylation analysis is a valuable prognostic tool for long-term outcomes in stage IV colorectal cancer. Patients with high levels of CHFR-rmv experienced significantly worse recurrence-free survival compared to those with low levels (p = 0.001), establishing CHFR-rmv as an independent prognostic factor (hazard ratio = 2.63). Likewise, high SOX11-rmv levels indicated poorer outcomes post-surgery (p = 0.004). These findings advocate for future investigations in this area.

• Why it matters: y

Journal Article by Momose H, Sugimoto K (…) Sakamoto K et 6 al. in J Surg Oncol

© 2024 Wiley Periodicals LLC.

read the whole article in J Surg Oncol

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in HPB & Spleen.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in HPB & Spleen

The latest stitches

Surg Endosc6 Nov 2026

A new cut for robotic liver surgery

A close-to-open cutting method was used for robotic liver resection, with no bile leaks and shorter hospital stays than after laparoscopy.

Surg Endosc6 Nov 2026

Robotic bile duct stone surgery: fewer complications

Removing large common bile duct stones with a robot rather than laparoscopically was linked to fewer complications and shorter hospital stays, at a higher cost, in a study from one Chinese hospital.

All papers in HPB & Spleen →